Equivariant Perturbation in Gomory and Johnson’s Infinite Group Problem. VII. Inverse Semigroup Theory, Closures, Decomposition of Perturbations
Open Journal of Mathematical Optimization · 2022
DOI: 10.5802/ojmo.16 ↗At a glance
Journal article in Open Journal of Mathematical Optimization, 2022. Written by Robert Hildebrand and 2 co-authors. 23 references.
Abstract (original language)
In this self-contained paper, we present a theory of the piecewise linear minimal valid functions for the 1-row Gomory–Johnson infinite group problem. The non-extreme minimal valid functions are those that admit effective perturbations. We give a precise description of the space of these perturbations as a direct sum of certain finite- and infinite-dimensional subspaces. The infinite-dimensional subspaces have partial symmetries; to describe them, we develop a theory of inverse semigroups of partial bijections, interacting with the functional equations satisfied by the perturbations. Our paper provides the foundation for grid-free algorithms for the Gomory–Johnson model, in particular for testing extremality of piecewise linear functions whose breakpoints are rational numbers with huge denominators.
Cite
APA
Hildebrand, R., Köppe, M., & Zhou, Y. (2022). Equivariant Perturbation in Gomory and Johnson’s Infinite Group Problem. VII. Inverse Semigroup Theory, Closures, Decomposition of Perturbations. Open Journal of Mathematical Optimization. https://doi.org/10.5802/ojmo.16
Vancouver
Hildebrand R, Köppe M, Zhou Y. Equivariant Perturbation in Gomory and Johnson’s Infinite Group Problem. VII. Inverse Semigroup Theory, Closures, Decomposition of Perturbations. Open Journal of Mathematical Optimization. 2022. doi:10.5802/ojmo.16
BibTeX
@article{Hildebrand2022,
author = {Hildebrand, Robert and Köppe, Matthias and Zhou, Yuan},
title = {Equivariant Perturbation in Gomory and Johnson’s Infinite Group Problem. VII. Inverse Semigroup Theory, Closures, Decomposition of Perturbations},
journal = {Open Journal of Mathematical Optimization},
year = {2022},
doi = {10.5802/ojmo.16}
}
EUVIMED